Stocks and Investing
Stocks and Investing
Wed, June 19, 2024
[ Wed, Jun 19th 2024
] - WOPRAI
Tue, June 18, 2024
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
Matthew Harrison Downgraded (ZNTL) to Hold and Decreased Target to $8 on, Jun 18th, 2024
Matthew Harrison of Morgan Stanley, Downgraded "Zentalis Pharmaceuticals, Inc." (ZNTL) to Hold and Decreased Target from $38 to $8 on, Jun 18th, 2024.
Matthew has made no other calls on ZNTL in the last 4 months.
There is 1 other peer that has a rating on ZNTL. Out of the 1 peers that are also analyzing ZNTL, all agrees with Matthew's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Robert Driscoll of "Wedbush" Maintained at Hold with Increased Target to $15 on, Wednesday, February 28th, 2024
Contributing Sources